Cargando…
Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival
SIMPLE SUMMARY: It is known that doxorubicin is one of the standards for chemotherapy treatment against Ewing sarcoma. Despite its widespread use, doxorubicin treatment initiates tumor escape mechanisms and disease relapse. Our study aims to identify the potential biomarkers of doxorubicin resistanc...
Autores principales: | Yakushov, Semyon, Menyailo, Maxim, Denisov, Evgeny, Karlina, Irina, Zainullina, Viktoria, Kirgizov, Kirill, Romantsova, Olga, Timashev, Peter, Ulasov, Ilya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688843/ https://www.ncbi.nlm.nih.gov/pubmed/36428591 http://dx.doi.org/10.3390/cancers14225498 |
Ejemplares similares
-
Latest developments in the pathobiology of Ewing sarcoma
por: Karlina, Irina, et al.
Publicado: (2022) -
Carbonic Anhydrase Inhibitors Induce Ferroptosis through Inhibition of AKT/FTH1 Signaling in Ewing Sarcoma Tumor Cells
por: Fayzullina, Darya, et al.
Publicado: (2023) -
Ewing sarcoma treatment: a gene therapy approach
por: Tsibulnikov, Sergey, et al.
Publicado: (2023) -
Novel Targeted Therapeutic Strategies for Ewing Sarcoma
por: Fayzullina, Daria, et al.
Publicado: (2022) -
Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds
por: Menyailo, Maxim E., et al.
Publicado: (2020)